Table 6.
Status of ESBL and representative ESBL genes among uropathogenic Escherichia coli from diabetic and nondiabetic patients
| Methods used | ESBL parameters | Number (%) in | P value | |
|---|---|---|---|---|
| Diabetic | Nondiabetic | |||
| Phenotypic, N = 66 (CD test) | ESBL producer | 12 (92.3) | 44 (83.0) | > 0.05 |
| ESBL non producer | 1 (7.7) | 9 (17.0) | ||
| Total | 13 | 53 | – | |
| Genotypic, N = 56 (blaTEM gene screening) | blaTEM detected | 5 (41.7) | 25 (56.8) | > 0.05 |
| blaTEM not detected | 7 (58.3) | 19 (43.2) | ||
| Total | 12 | 44 | – | |
| Genotypic, N = 56 (blaCTX-M gene screening) | blaCTX-M detected | 10 (83.3) | 39 (88.6) | > 0.05 |
| blaCTX-M not detected | 2 (16.7) | 5 (11.4) | ||
| Total | 12 | 44 | – | |
ESBL = extended spectrum β-lactamase.